Reports have surfaced indicating that the Biden administration is gearing up to shake up federal drug policy. The U.S. Drug Enforcement Administration (DEA) is reportedly considering reclassifying marijuana, a move that could mark a significant shift in decades-long restrictions.
According to NBC News, the DEA is set to greenlight an opinion from the Department of Health and Human Service proposing that marijuana be downgraded from a Schedule I drug to a Schedule III drug. This reclassification would signal a recognition of the drug's potential medical benefits and its comparatively lower risk of abuse compared to other substances.
